(Q39237707)

English

A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.

scientific article published on 25 July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

0 references

Adam J. Shuhendler

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Preethy Prasad

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Michael Leung

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Andrew M Rauth

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ralph S Dacosta

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Xiao Yu Wu

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

25 July 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Advanced Healthcare Materials

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

600-608

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Integrins in cancer: biological implications and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Integrin targeted drug and gene delivery

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Mechanisms of angiogenesis and arteriogenesis

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Multimodality Imaging of Integrin α(v)β(3) Expression

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Passive and active drug targeting: drug delivery to tumors as an example

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Liposomes modified with cyclic RGD peptide for tumor targeting

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Hybrid quantum dot-fatty ester stealth nanoparticles: toward clinically relevant in vivo optical imaging of deep tissue

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Dual functionality of the anti-beta1 integrin antibody, 12G10, exemplifies agonistic signalling from the ligand binding pocket of integrin adhesion receptors.

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Homogenized tissue phantoms for quantitative evaluation of subsurface fluorescence contrast.

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Lead distribution in blood and organs of mice exposed to lead by vein injection.

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

The architecture of ligand attachment to nanocarriers controls their specific interaction with target cells

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Dissecting tumour pathophysiology using intravital microscopy

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Radiation-guided targeting of combretastatin encapsulated immunoliposomes to mammary tumors.

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Peptide-targeted PEG-liposomes in anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Present and future evolution of advanced breast cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Multivalent effects of RGD peptides obtained by nanoparticle display

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

In vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels.

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200006

21 January 2018

Identifiers

10.1002/ADHM.201200006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

release_vysrvjmujreulobwyod4cmuqzy

1 reference

https://api.fatcat.wiki/v0/release/vysrvjmujreulobwyod4cmuqzy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184795%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39237707&oldid=1843201373"